 | MacroGenics (NASDAQ:MGNX) Lowered to Hold at Zacks Investment Research
marketbeat.com - August 5 at 4:27 AM |
 | MacroGenics Inc (NASDAQ:MGNX) Short Interest Update
americanbankingnews.com - August 7 at 7:55 PM |
 | MacroGenics to Participate in Upcoming Investor Conferences - GlobeNewswire
globenewswire.com - August 5 at 5:00 PM |
| Short Interest in MacroGenics Inc (NASDAQ:MGNX) Drops By 9.4%
americanbankingnews.com - August 3 at 7:10 PM |
| MacroGenics (NASDAQ:MGNX) Downgraded to Neutral at Citigroup
www.americanbankingnews.com - August 3 at 8:29 AM |
| MacroGenics Inc (NASDAQ:MGNX) Expected to Post Quarterly Sales of $14.88 Million
www.americanbankingnews.com - August 3 at 3:01 AM |
| MacroGenics (NASDAQ:MGNX) Issues Earnings Results, Misses Estimates By $0.02 EPS
www.americanbankingnews.com - August 1 at 8:12 PM |
| -$0.85 EPS Expected for MacroGenics Inc (NASDAQ:MGNX) This Quarter
www.americanbankingnews.com - August 1 at 9:09 AM |
 | MacroGenics (MGNX) Q2 2020 Earnings Call Transcript - Motley Fool
www.fool.com - August 1 at 8:53 AM |
 | MacroGenics (MGNX) Q2 2020 Earnings Call Transcript
finance.yahoo.com - August 1 at 3:52 AM |
|
 | MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 31 at 10:52 PM |
| Edited Transcript of MGNX.OQ earnings conference call or presentation 30-Jul-20 8:30pm GMT - Yahoo Finance
finance.yahoo.com - July 31 at 5:51 PM |
| MacroGenics (NASDAQ:MGNX) Stock Rating Reaffirmed by HC Wainwright
www.americanbankingnews.com - July 31 at 9:27 AM |
| MacroGenics (NASDAQ:MGNX) Price Target Increased to $12.00 by Analysts at Morgan Stanley
www.americanbankingnews.com - July 31 at 9:26 AM |
 | ImmunoGen Reports Recent Progress and Second Quarter 2020 Financial Results - Business Wire
www.businesswire.com - July 31 at 7:51 AM |
| Is MacroGenics, Inc. (NASDAQ:MGNX) Trading At A 37% Discount?
finance.yahoo.com - July 31 at 7:51 AM |
 | Macrogenics (MGNX) Tops Q2 EPS by 8c, Revenues Beat - StreetInsider.com
www.streetinsider.com - July 30 at 8:21 PM |
| MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - July 30 at 8:21 PM |
| MacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial Results - GlobeNewswire
www.globenewswire.com - July 30 at 8:21 PM |
| MacroGenics Provides Update on Corporate Progress and Second Quarter 2020 Financial Results
finance.yahoo.com - July 30 at 8:21 PM |
| MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - July 30 at 8:21 PM |
| MacroGenics Inc (NASDAQ:MGNX) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - July 28 at 4:13 PM |
| MacroGenics (MGNX) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - July 24 at 9:18 AM |
| Earnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline - Yahoo Finance
finance.yahoo.com - July 23 at 9:53 AM |
| MacroGenics Announces Date of Second Quarter 2020 Financial Results Conference Call - Yahoo Finance
finance.yahoo.com - July 23 at 9:53 AM |
| MacroGenics Announces Date of Second Quarter 2020 Financial Results Conference Call
finance.yahoo.com - July 23 at 9:53 AM |
 | Earnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline - Nasdaq
www.nasdaq.com - July 22 at 2:38 PM |
| Earnings Preview: MacroGenics (MGNX) Q2 Earnings Expected to Decline
finance.yahoo.com - July 22 at 2:38 PM |
| MacroGenics (NASDAQ:MGNX) PT Raised to $11.00
www.americanbankingnews.com - July 16 at 6:07 AM |
| Here's Why MacroGenics Jumped 156.6% in the First Half of 2020 - Motley Fool
www.fool.com - July 10 at 8:42 AM |
|
| MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer - GlobeNewswire
www.globenewswire.com - July 9 at 7:15 PM |
| Here's Why MacroGenics Jumped 156.6% in the First Half of 2020
finance.yahoo.com - July 9 at 7:15 PM |
| MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer
finance.yahoo.com - July 9 at 7:15 PM |
| The Play On MacroGenics - Seeking Alpha
seekingalpha.com - July 6 at 7:46 PM |
| Is MacroGenics Inc (MGNX) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - June 28 at 12:24 AM |
| Is MacroGenics Inc (MGNX) A Good Stock To Buy?
finance.yahoo.com - June 28 at 12:24 AM |
 | BRIEF-Macrogenics Announces Presentation Of Preclinical Data - Reuters
www.reuters.com - June 22 at 12:57 PM |
| MacroGenics Announces Presentation of Preclinical Data at the 2020 AACR Annual Meeting - GlobeNewswire
www.globenewswire.com - June 22 at 12:57 PM |
| MacroGenics Announces Presentation of Preclinical Data at the 2020 AACR Annual Meeting
finance.yahoo.com - June 22 at 12:57 PM |
| MacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer - GlobeNewswire
www.globenewswire.com - June 16 at 8:38 AM |
| MacroGenics Appoints Dr. Stephen Eck As Chief Medical Officer
finance.yahoo.com - June 16 at 8:38 AM |
| Macrogenics (MGNX) Announces Margetuximab Granted Orphan Drug Designation in the US for Gastric Cancer - StreetInsider.com
www.streetinsider.com - June 6 at 12:14 AM |
| MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S. for Gastric Cancer - GlobeNewswire
www.globenewswire.com - June 5 at 2:13 PM |
 | Why MacroGenics Is Moving Today
www.benzinga.com - June 5 at 11:36 AM |
| MacroGenics' margetuximab an Orphan Drug in U.S. for gastric cancer
seekingalpha.com - June 5 at 9:11 AM |
| MacroGenics Announces Margetuximab Granted Orphan Drug Designation in the U.S. for Gastric Cancer
finance.yahoo.com - June 5 at 9:11 AM |
| MacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid Leukemia - GlobeNewswire
www.globenewswire.com - June 3 at 7:08 PM |
| MacroGenics Announces Publication in Science Translational Medicine Supporting Flotetuzumab Pivotal Study in Patients with Refractory Acute Myeloid Leukemia
finance.yahoo.com - June 3 at 7:08 PM |
| UPDATE: Guggenheim Upgrades MacroGenics (MGNX) to Buy - StreetInsider.com
www.streetinsider.com - June 1 at 9:07 AM |
| Here's Why MacroGenics Is Tumbling 17.3% Today - Motley Fool
www.fool.com - May 29 at 1:12 PM |
| Here's Why MacroGenics Is Tumbling 17.3% Today
finance.yahoo.com - May 29 at 1:11 PM |
